Endocrine System

General Concepts

Homeostatic control

Endocrine cell (ductless) -> blood -> target cell (receptor)

Low conc. in plasma, high affinity, binds and stays (effects for a period of time)

Neuron -> synapse -> effector cell

Synapse is a tiny space, with high conc. of neurotransmitters, low affinity with quick control

Paracrine

Local Control

Autocrine

Self Control

Gap Junction

Contact Control

Endocrine glands

Ductless glands, secretions delivered by blood to target tissues

Regulate

Na and H2O balance

Ca balance

Energy Balance

Processes that cope with stress

Growth and development

Processes associated with Reproduction

Concentration and Function

Too much

Hyper secretion, hormone excess

Can also be turned off

Too litle

Hypo secretion, hormone insufficiency

Target cell resistance

Unresponsive to hormone

Eusecretion

Just nice

Regulated by

Rate of production

  • mediated by + and - feedbacks

Rate of delivery: dependent on perfusion and mass action law

Rate of excretion/ degradation: half life in circulation

Mass action law: Hormones bound to carriers that are of lower affinity than receptors -> net transfer of hormones from carriers to receptors

Bound hormones to carriers have longer half life

Three types of hormones

Peptide and protein hormones

Pre-prohormone in RER , cleaved to prohormone in GA, Cleaved to hormone in secretory vesicle

Same synthesis and processing as secretory proteins, stored in secretory vesicle, soluble in plasma and usually not bound to carrier, short half life

Steroid hormones

Cholesterol -> Pregnenolone -> steroid hormones (different types)

Insoluble in plasma, transported via carrier proteins, synthesized and secreted on demand (cannot be stored), conversion in target tissues

Secreted by adrenal glands, gonads and placenta

Amino acid derivatives

  • from tyrosine

Epinephrine

soluble in plasma, short half life, in medulla of adrenal gland

Throxine (Thyroid hormones)

Insoluble in plasma, transported via carrier, long half life, conversion in target tissues

Role of carrier proteins

Synthesized by liver

Extend half life in circulation

Sequesters hormone from target cell receptor

Total concentration = bound + free (active)

Mass action law

Receptor types and signaling

Cell surface

e.g. tyrosine kinase linked, inherent tyrosine kinase, Gprotein coupled

Secondary messenger signaling -> rapid metabolic changes

For steroid and thyroid hormones

Able to cross plasma membrane

Intracellular/nuclear receptor

Affect DNA transcription, change phenotype of cells, takes longer to change but have longer effects

Receptors determine Target cell response

Affinity

Conc. of hormone for half maximal response

High affinity -> low conc needed

Receptor no.

Cells with more receptors are more sensi to hormone

Competition

Binding by other agonist( or antagonist) reduces sensitivity

e.g. cortisol vs aldosterone

Saturation

Hormone conc. when all receptors are bound

remove hormone -> increase receptors to increase sensitivity due to less available hormone -> give hormone -> huge effect (rebound)

Types of reflex loops

Neural Control

  • e.g. posterior pituitary

Increase [osmol] (stimulus) -> neuron -> ADH release -> kidney (target cell)

Hormonal control

  • e.g. anterior pituitary
  • H1 is tropic hormone for H2

Lower glucose (S) -> Hypothalamus -> GHRH (H1) -> AP -> GH (H2) -> LIVER (IGF-1)

Substrate Control
e.g. pancreatic islet, parathyroid

decrease [Ca] -> parathyroid -> PTH -> Bone (release Ca and PO4

Inactivation of response

Clearance: Removal of hormone

Receptor down regulation:
Sequestraion (remove receptor) or uncoupling

Removal of stimulus (-ve feedback)

Quantitative assays

Mix labeled hormone and hormone in plasma/urine with specific antibody

Mix of labeled and unlabeled hormone-AB complex

High sensitivity and specificity

Labels radioactive or fluorescent -> measure intensity

Can tell quantity, but cant tell if active

Bio assays: test for feedback loop activity

For hyposecretion of H-P-Adrenal axis

Use stimulation test to evaluate dysfunctional site leading to low cortisol

Give ACTH to promote cortisol secretion, assay cortisol levels after 60-90 minutes

If cortisol remains low -> adrenal dysfunctional (primary)

If cortisol increases -> either pituitary or hypothalamus is dysfunctional

For Hypersecretion of H-P-Adrenal Axis

Use suppresion test to evaluate site leading to high secretion of cortisol

give Dexamethasone to inhibit ACTH secretion, assay cortisol levels after 60-90 mins

If cortisol remains high, adrenal gland dysfunctional

If cortisol decreases, either pituitary or hypothalamus is dysfunction

Classification of pathology

Hypothalamus-Pituitary Axis

Regulates homeostasis

Hypothalamus secretes neuropeptides that control pituitary function in response to afferent signals from the brain, viscera and circulating levels of substrates and hormones

Pituitary secretes 8 hormones

Act directly on non-endocrine tissues (GH, PRL, ADH AND OT)

Act to modulate other endocrine glands (ACTH, TSH, FSH AND LH) and are called tropic peptides

  • increase in size and no. of cells

Embryonic development

Posterior pituitary

When the diencephalon (brain) extends caudally

Joins with anterior pituitary, forming the median eminence (closest to brain), infundibulum (stalk) and pars nervosa

Consists of neural tissue

Anterior pituitary

Root of mouth loops up, forming Rathke's pouch

cuff formed around infundibulum -> pars tuberalis

Pars distalis (glandular tissue, forming anterior pituitary)

Unsealed loops of the pouch forms cysts and pars intermedia (between the two laeyers, consisting of glandular cells protruding into neural tissue)

Two portal systems

Hypothalamus to anterior pituitary

Posterior to anterior pituitary

Superior hypophyseal artery -> median eminence (receive releasing factors) -> long portal vessels -> anterior

Inferior hypophyseal artery -> posterior (receive ADH) -> short portal vessels -> anterior

Neurons in hypothalamus

Parvocellular neurons of paraventricular nucleus

Magnocellular neurons in supraoptic nucleus and PVN

Terminate in median eminence and secrete releasing factors (+ and -)

Secrete OT and ADH into capillaries of posterior lobe

Supraoptic -> ADH

PVN -> OT and abit of ADH

Hypothalamic neuropeptides

Called releasing factors (or inhibiting factors)

Secreted in episodic (perhaps circadian) and pulsatile manner

  • Pulsatile to prevent down regulation from over secretions

Present at high conc. at target cell

Present in very low conc. in systemic blood

Releasing factors bind to plasma membrane receptors in pituitary target cells, release stored target hormone by exocytosis (short term) and increase transcription of target hormones

  • will cause increase in size (hypertrophy) and number (hyperplasia) of target cells

Modulates own receptor activity (up/down regulation)

Feedback and chart

Growth Hormone

Secretion of GH in adults

Pulsatile and circadian rhythm

Increasing during early sleep

Decreased amplitude due to increase plasma glucose and aging

Activated by sleep, stress (depends) and low serum glucose, inhibited by high glucose

GH and Melanocortin axes

Empty stomach activates ghrelin (growth hormone releasing hormone), which activates the anterior pituitary to release GH, goes to liver, and releases IGF

  • helps mobilize glucose and burnfat

Ghrelin also activates the hypothalamus Arcuate nucleus, which then inhibits Melanocortin receptors (MC4R) which originally decreases feeding

  • thus increases feeding

Biological role

click to edit

Increases muscle (Decrease fuel storage)

Activates IGF-1 in the liver

Increase size and function of internal organs

  • e.g. lung, heart, kidney

Lengthening of bones (together with GH directly)

In excess, GH is a diabetogenic, leading to hyperglycemia, lipolysis and hyperinsulinemia

GH, feeding and exercise

Diet

Amino acid

Insulin: yes

GH: yes

Effect: increase growth of muscle (seen with anaerobic training, not with aerobic

Glucose

Insulin: Yes

GH: No (Due to glucose intake)

Increase muscle glycogen (store)

Low glucose

Insulin: No

GH: yes (due to low glucose)

Effect: burn fuel from fat

GH excess

Before puberty

Gigantism

Overall increase in height in size as epiphyseal plate of bones are not closed yet

After puberty: Acromegaly

Coarsening of facial features, widening of fingers, toes, hands, feet

Prominent eyebrow ridge and jaws

All organs increase in size

Not good if it doesnt grow with axis of the body -> internal organ failure

  • no lengthening of body due to mature epiphyseal plate

Give somatostatin or ablate pituitary tumor

IGF-1 will increase

Regulation of anterior pit

H-P-Thyroid axis

TRH-TSH-T4/T3

H-P-Adrenal

CRH-ACTH-Cortisol

H-P-Gonad

Kisspeptin-GnRH-LH/FSH-gonad

Posterior Pit

Receive unmyelinated axons from magnocellular neurons in PVN and supraoptic nucleus, which secretes OT and ADH into posterior pituitary

Oxytocin

Regulated by sucking and cry of infant

Increases myoepithelial contraction in breast and increases bonding (also contraction of uterin lining)

For both genders: sexual climax, stroking or hugging the baby for bonding

ADH

Regulated by osmotic and volume stimuli

rise in plasma osmolarity

Decrease of 15-20% in total blood vol, cardiac output or blood pressure

Act to raise blood vol by increasing reabsorption of water

Bind plasma membrane receptors, increase transcription of target genes, secondary messengers are Ca2+, DAG and cAMP

Pathology

Diabetes Insipidus

Central lesion due to trauma, inflammation or tumor

Nephrogenic lesion

X-linked (defective vasopressin receptor)

Autosomal: defective aquaporin-2 channels

Acquired: lithium treatment, hypokalemia and post-obstructive polyuria

Excess water intake

In stress

ADH and CRH secreted into median eminence enter anterior lobe by long portal vessels

ADH from posterior love enters anterior lobe by short portal vessels

Cosecretion of ADH with CRH potentiates ACTH secretion from anterior lobe

Thyroid Gland

Thyroid follicle and thyroid cells

Follicle (colloid) contains thyroglobulin, follicular cells produce and process the thyroglobulin

In normal thyroid follicle, the cells are cuboidal

In hyperthyroid follicle, cells are columnar due to extensive processing, with little follicle space as most of it has been used to produce thyroid hormones

In hypothyroid, cells are almost squamous due to almost no processing, while follicle is huge due to thyroglobulin still being retained inside

Thyroid hormone

Follicular Cell function

Number based on number of iodine

need 2 iodine on the inner ring to be active

relative activity: T3 > T4 > rT3 (inactive)

Synthesis

Na+-K+ ATPase transports Na+ out in exchange for 1 K+ in

Na+ iodide cotransporter moves in one iodide with 1 Na+

Iodide then converted to iodine

Thyroglobulin produced by RER of follicle cells and secreted into the lumen of the follicles for storage as colloid

Luminal membrane bound peroxidase conjugates adjacent pairs of tyrosines and adds iodine to the tyrosine residues

Resultant iodinated thyroglobulin in the preprohormone (2-3 months of supply)

In the absence of iodide, TH is not made

2 active hormones: Thyroxine (T4) and triiodothyronine (T3)

In response to TSH, iodinated thyroglobulin is endocytosed and cleaved to generate TH, which leaves the gland by a transporter (MCT) to enter the blood

Normal thyroid to serum ratio is 25:1, but in hyperthyroid, excess TSH can increase Na+-I symporters, increasing the activity and raising the ratio to at least 250:1

Each consist of two iodinated phenoli rings

Conversion of prohormone T4 to T3 occurs in the thyroid gland and in target tissues

Both are lipophilic with low solubility in plasma, bound to low affinity carrier proteins

less than 0.2% is free in the serum, and only free TH enters target cell

Despite lipid solubility, it was demonstrated that humans have two cell membrane bound transporters: MCT8 and OATP

MCT in particular is critical for uptake of TH from circulation across BBB and indirectly across CSF barrier into CNS neurons

Loss of MCT8 activity in humans results inprofound mental and motor retardation (Allan-Herndon-Dudley syndrome)

T4:T3 in plasma is 20:1

central regulation

Hypothalamus: parvocellular cells of PVN secrete TRH, which determines set point for axis

Goes to pituitary, secrete TSH, used to assay activity of thyroid gland

Thermal signals, caloric signals, leptin from fat regulates

Cold and feeding increase TRH production

Conversion in Target Tissues

BMR response to single equimolar dose of T3 will be higher than T4

T4 has longer half life, but also lower biological activity

Prohormone, T4, is converted to T3 in the thyroid gland and in target tissues, T3 therefore provides feedback

deiodinases regulate conversion

D1

Peripheral tissues, on plasma membrane, converts T4 to T3 + rT3

Determine T3 pool in hyperthyroidism, inhibited by propylthiouracil

D3

some peripheral tissues, fetus and placental unit

On plasma membrane

T4 converted to rT3

For clearance to clear body of T3 and T4

D2

In CNS, skeletal muscles, fat, heart, bone and thyroid gland

Activity increased by TH depletion and by increase sympathetic NS stimulation

determines 50% or more of T3 levels in eu and hypothyroid states, active in development and thermiogenesis

  • skeletal muscle and brown fat

Perinuclear ER

Bound thyroid hormone receptor turns on transcription

Activate Na-K-ATPase, beta adrenergic receptors (increase HR), Glut 4 (increase glucose entrance into muscle) and others

TR saturation maximal in cells expressing D2

TR saturation minimal in cells expressing D3

Alters metabolism and thermogenesis

Accelerates Basal metabolic rate

Burns ATP, muscle and fat

Increase GLUT 4 in skeletal muscle

Increase rate of lipolysis and lipogenesis (to replace stores)

Thermogenesis by mitochondrial uncoupling

Adrenergic receptor upregulates uncoupling proteins (UCP) which is driven by free fatty acids fromlipolysis

In brown fat of fetus (UCP1)

In skeletal muscle of adult (UCP3)

during fasting

Free T4, Free T3 and TSH should decrease (with T3 decreasing to a greater extend)

D1 down regulated during fasting (T4 will thus be primary active form, lowering BMR)

D2 doesnt change in CNS, heart, thyroid gland and skeletal muscle to preserve activity, mediates feedback regulation in pituitary

leptin levels modulate TRH and TSH in starvation

High leptin will increase levels of TRH and on (fed state)

Will also activate melanocortin receptors, which inhibits feeding

Specific Tissue Actions

CVS

Hyper: increase HR, contractility and cardiac output, vasodilation

Reflects upregulation of beta adrenergic receptors

CNS

Hypo: mental Fog, lethargic, fatigue

Hyper: anxious, hand tremors, anxiety, weakness

Reproductive system and growth

Hypo: infertility, decrease LH secretion, retarded growth

Skin

Hypo: dry and puffy skin, hair loss, cold intolerance

Hyper: sweaty skin, heat intolerance, dryness or bulging of eyes

Pathologies

Hypothyroidism

Goiters

One of the most acquired endocrine disorders

Can occur with dietary iodine deficiency

Can also happen in hyperthyroidism

Hashimoto's thyroiditis

autoimmune disease that triggers apoptosis in thyroid follicular cells

Gland overstimulated

Congenital hypothyroidism (Creinism)

Partially reversible growth retardation

Irreversible mental retardation

Hyperthyroidism

present with exophthalamus (bulging eyes)

Grave's disease

Autoimmune disease in which circulating antibodies mimic TSH activity

T3 and T4 levels are high, TSH low

Goiters form due to overstimulation

Thyroid storm

True Emergency: Tachycardia, sweating, high fever

Treat with beta blocker, propylthiouracil (PTU) to inhibit iodination of thyroglobulin and D1 activity

Glucocorticoids to stimulate D3 activity

Parathyroid gland and Calcium homeostasis

Calcium involved in

Synaptic transmission and secretion

Second messenger

Protein secretion

Motility

differentiation and gene expression

Two time scales

Rapid transfer of calcium between ECF and bone -> moment to moment regulation

Slow rate: ingestion into and excretion from body

PTH governs both rapid and slow responses

regulation of plasma Ca

Exist as three forms: 50% ionized, 40% reversibly bound to protein, 10% bound to anions such as phosphate and citrate

Ionized and anion bound is filterable by kidney

Only free ionized Ca2+ is biologically active

pH is one of the most impt influences on amount of ionized Ca2+ in the blood

negatively charged plasma proteins have anionic sites that bind H+ or Ca2+

As pH rises, H+ dissociate from these sites and Ca2+ ions take its place, lowering plasma Ca2+

Patient with acute alkalosis is more susceptable to tetany (intermittent muscular spasms)

Ca2+ homeostasis = mass balance

PTH and Vit D govern movement of Ca2+

positive balance (growing child), net Ca2+ absorption from GI tract exceeds urinary excretion, difference is deposited in the bone

Negative Ca2+ balance (lactating mother), Ca2+ absorption from GI tract is insufficient and difference comes from bones

Parathyroid Hormone (PTH)

regulates serum ionized Ca2+ conc. byacting on bone, kidney and intestine

Net effect is to raise serum Ca2+ and simultaneously decrease serum phosphate conc

humans have 4 parathyroid glands, of which the chief cells produce the PTH

  • produced as preprohormone, cleaved and stored

regulated by plasma Ca2+ conc. in simple -ve feedback

  • When Ca in ECF is normal range or higher, PTH secreted at low basal rate

When decrease <10, PTH secretion strongly stimulated through a sensor coupled via G protein to adenylyl cyclase -> increase cAMP levels

Actions of PTH

Primarily to kidney and bone, where it binds to cells expressing PTH receptor (PTHR)

Bone

Affects all three cell types: osteocytes, osteoclasts and osteoblasts

occurs in phases

  1. Rapid absorption of Ca2+ into blood from fluid within bone canaliculli
  1. Slower reabsorption of Ca2+ into blood due to osteoclast degradation of mineralized bone which releases Ca2+ and phosphate into the ECF and degrades organic matrix of bone
  1. Late inhibition of osteoblasts prevent bone formation

doesnt directly affect osteoclasts (no receptors), could be paracrine signals from osteoblasts and osteocytes

Kidney

Promote phosphate excretion into urine by decreasing phosphate reabsorption in proximal renal tubules

  • prevent deposition of Calcium Phosphate, an insoluble precipitate, within tissues and blood

Stimulate Ca2+ reabsorption in the distal renal tubules

PTH also increases conversion of VitD to its active form, calcitriol which acts on GI tract to promote uptake of Ca2_

Pathologies

Hyperparathyroidism

Primary: tumors (adenoma) that secrete excess PTH, blood Ca2+ elevated, PTH is high, surgery needed

Secondary: because of hypocalcemia due to chronic renal failure or Vit D deficiency, blood Ca2+ low but PTH high

Hypoparathyroidism

Consequence of thyroid or parathyroid surgery

Low circulating levels of PTH, decreased bone resorption and decrease Ca2+ reabsorption

Plasma Ca2+ low and phosphate is high

Also contain parafollicular cells (C cells) that secretes calcitonin (antagonist of PTH) to decrease blood calcium

  • found outside follicles, fill in space between them

Pancreas
(Insulin and Glucagon)

In mammals, metabolism classified as 1 of 2 states

Fed state (anabolic)

Fasted state (Catabolic)

Immediately following a meal

Energy of nutrient molecules is transferred to high energy compounds for either immediate use or storage

When available nutrients in blood decreases, stored reserves mobilized either to perform work or generate heat

Most impt aspect of metabolism is regulated use of carbs, proteins and fats to generate glucose

Plasma glucose closely regulated at 80-100 mg/dL

Hour to hour regulation of glucose depends on antagonistic activities of insulin and glucagon (pancreatic hormones)

Control of hormones by factors such as diet, nutritional status and stress

high insulin:glucagon -> fed state and activates anabolic pathways

  • storage of glucose as glycogen and fatty acids as triglycerides

High Glucagon:insulin -> fasting or "fight or flight" state -> increased levels of blood glucose (from glycogenolysis) and glycerol from lipolysis of fat

  • free fatty acids used to generate ketones in the liver

Insulin secreted by pancreatic islet B cells when blood glucose higher than 80mg/dL
Glucagon secreted when blood glucose levels lower than 80mg/dL

Levels of insulin depend on blood glucose levels while levels of glucagon remains relatively steady during 24 hr period

Insulin and glucagon from pancreas

B cells in islets (more towards the core, bulk of the cells) produce insulin, ACh primes B cells secretion of insulin, but does so in a paracrine manner

a cells secrete glucagon

D cells produce somatostatin, PP cells secrete pancreatic polypeptide, e cells secrete ghrelin

Insulin

produced in RER as preproinsulin, where leader seq removed in ER and disulfide bonds formed to make proinsulin

Transferred to GA, where it is packed in secretory vesicles, and is further cleaved to remove the connecting peptide (C peptide), giving A and B chains of insulin

Removal of C-peptide exposes COOH terminal of insulin's B chain, allowing interaction of insulin receptor

C peptide stored with insulin, released and is an active peptide hormone involved in activation of Ca2+ dependent signaling pathways in renal and nerve tissues

Glucose timulation of insulin secretion

  1. when blood glucose rise >80mg/dL, glucose enters B cells via GLUT 2
  1. As glc enters, phosphorylated by glucose kinase to form G6P
  1. G6P metabolized (glycolysis), small increase in cytosolic ATP conc.
  1. Rise inhibits ATP gated K channels, which governs membrane potential
  1. When K channel close, no more K+ efflux, cell membrane depolarizes, opening voltage gated Ca2+ channels and Ca2+ enters
  1. influx activates phospholipase C, leading to production of diacylglycerol (DAG) and inositol phosphate (IP3)
  1. IP3 triggers Ca2+ release from ER, lead to secretion of insulin
  1. secretion terminated by activation of voltage gated K+ channels

In humans, IV infusion of glucose results in a biphasic pattern of secretion

Initial burst (5-10mins) of stored insulin

  • Requires expression of insulin receptors on B cells

Second prolonged (30mins) phase of newly synthesized insulin

  • Requires cell to cell contact between B cells and paracrine signalling

modulators of secretion

Hyperglycemia, elevated plasma amino acids and long chain fatty acids, as well as signals from autonomic nervous system and the GIT

e.g. consumption instead of IV glucose results in higher secretion of insulin due to incretin effect in response to carbs within the intestinal lumen

short chain fatty acids inhibit insulin secretion, somatostatin and catecholamines

Sulfonylurea drugs close ATP gated K+ channels, increasing insulin secretion from B islet cells in a subclass of DMTII individuals

Mechanism

Promtoes uptake of glucose from blood into cells

Enters all cells by GLUT 1 OR GLUT 2

in skeletal muscles and adipocytes, act to enhance by moving GLUT 4 to cell surface, glucose in cells kept low by rapid phosphorylation to G6P

Inactivation due to aggregation and endocytosis of insulin receptors, destruction in endosomes, degraded in liver and kidney

Promotes glycogen synthesis, inhibit glycogen degradation (improve glucose storage)

Stimulate lipogenesis and suppres lipolysis in adipose tissue, skeletal muscle and liver, inhibit hormone sensitive lipase resulting in accumulation of triglycerides and increase uptake of fatty acids from blood into adipose tissue and stored as triglycerides

stimulates amino acid transport into liver, skeletal muscle and fats, increase protein synthesis and inhibit protein degradation

deficiency

reduce flucose uptake into fat and muscle, excess glucose in blood and added production of glucose by liver

catabolism of protein, fat and glycogen and insufficient storage

Secretion of glucagon elevated, increasing lipolysis and gluconeogenesis

First consequence is protein deficiency, then overload of catabolic pathways wtih free fatty acids and triglycerides, which the liver converts to ketone bodies

As circulating levels of kotene rise, pH drops

Glucose excreted in urine

Diabetes Mellitus

Type 1 (insulin dependent diabetes mellitus, IDDM)

inability of pancreatic B cells to produce insulin

Must be injected with insulin daily

Long term control depends on maintaining balance between 3 factors: diet, exercise and insulin

Non-insulin-dependent diabetes mellitus (NIDDM or type 2)

Relative failure of pancreatic cell and/or by insulin resistance in muscle, fat and liver

rough stages

  1. Skeletal muscle first develops insulin resistance, leading to reduced GLUT 4 activity
  1. increased secretion of insulin followin gglucose ingestion -> increased insulin levels with normal glucose
  1. progression to pre-diabetic state characterized by loss of first phase of glucose dependent insulin secretion by pancreatic B cells as well as prolonged hyperinsulinemia and hyperglycemia
  1. High circulating levels of insulin diverts liver metabolism away from glycogen synthesis to glucose and fatty acid synthesis in response to glucose ingestion -> elevated plasma fatty acids, hyperglycemia and hyperinsulinemia

Dietary restriction supplemented with sulfonylurea drugs to enhance response of pancreatic B cells to glucose, with glitazone to reduce peripheral insulin resistance

In obesity related NIDDM, impaired capacity to switch between fed and fasting, leading to ectopic accumulation of fat in muscle and liver, leading to down regulation of insulin receptor and impaired GLUT 4 translocation to cell surface

  • aerobic exercise and weight loss recomended, correcting islet B cell abnormalities and increasing insulin stimulated glucose uptake in skeletal muscles

In Maturity Onset Diabetes in the Young (MODY), mutations of glucokinase gene is the cause

  • pt mutations in glucokniase gene alter sensitivity of islet B cell, requiring higher glucose levels to trigger insulin release

Gestational DM, during pregnancy

Acute complications

Ketoacidosis (metabolic) -> reduce blood vol, renal failure, coma and death

Hyper glycemia lead to fluid loss and dehydration (glucose in urine, increased urine output, loss of electrolytes)-> hyperosmolar coma

Corrective measuresL administration of base, fluids and insulin

Chronic Complications

circulatory and nervous systems

Deterioration of

Blood flow to retina of eye, causing retinopathy and blindness

BLood flow to extremities, causing need for amputation

Glomerular filtration in kidneys -> renal failure

Diminished sensation in extremities, impaired bladder and bowel functions

C-peptide replacement along with insulin may prevent development or retard progression of chronic complications in Type I disease

Glucagon

synthesized initially as preprohormone and is cleaved, released from pancreatic islet a cells when glucose <80mg/dL

Circulates unbound in plasma

potent hyperglycemic agent, acts on liver to promote gluconeogenesis but not in muscle, promotes glycogenolysis and ketone synthesis

Interact with cell surface receptors (G protein coupled receptor) which activates cAMP and Ca2+ (due to adenylate cyclase and release of IP3 respectively)

regulation

rise in plasma glucose levels >80mg/dL, enters cell, metabolized and glycolysed to form ATP, close K-ATP channel, leading to depolarization of cell

depolarization open voltage gated Ca2+ and Na+ channel, inhibition of glucagon secretion

Also regulated by insulin, where its presence potentiates suppressive effects of high glc

depolarization of B cell and entry of Ca2+ leads to depolarization of adjacent d-cell (gap junction) and secretion of somatostatin, which acts to hyperpolarize neighbouring a cell, inhibiting glucagon secretion

in Type I and type II diabetes (insulin resistance), no regulation of glucagon, thus baseline elevated

Stress increases glucagon secretion, mediated by sympathetic system to alpha adrenergic receptors and a and B islet cells, inhibiting insulin secretion, and promoting glucagon secretion

Adrenal Glands

Adrenal gland produces 3 major classes of hormones, net effect to maintain electrolyte balance, BP, plasma glucose levels and to suppress immune system

Split into two parts

Cortex

Medulla

mineralcorticoid (Aldosterone) on the outer layer (zona glomerulosa)

Glucocorticoid (cortisol) in zona fasciculata)

Sex Hormone (DHEA) in zona reticularis

epinephrine and norepinephrine

Hormones

Mineralcorticoids (aldosterone)

Glucocorticoids (cortisol)

Sex hormones (DHEA)

Maintains electrolyte and fluid balance

Affected by 21 and 11-hydroxylase (deificiency will cause no production of aldosterone)

Mobilize fueal depots, increasing plasma glucose

deficiency in 17,11 and 21 hydroxylase will cause no cortisol in system

weak ANDROGEN

Deficiency is 17 hydroxylase will cause no DHEA in system

Mineralcorticoids

in absence of aldosterone, plasma K+ levels increase with dietary intake and can reach life threatening levels

receptor found in many epithelial cells, including those that line the distal tubule of kidney and colon

Signals

Elevated angiotensin II due to low blood volume

elevated plasma K+

decrease inm serum K inhibits ANGII -stimulated release of aldosterone to prevent severe hypokalemia

elevated Na+ inhibits aldosterone release and activation of renin-angiotensin II by kidney

act on the kidney to increase reabsorption of Na+ and water and increase excretion of K+ in urine

acutely, ACTH from anterior pituitary will stimulate aldosterone production from z. glomerulosa, but aldosterone does not regulate the H-P-Adrenal axis (ACTH asecondary activator of aldosterone

Aldosterone bind to mineralcorticoid receptor of principal cells in kidney, increasing transcription of Na+ and K+ transporters on apical surface and of Na+-K+ ATPase on basolateral surface, resulting in increase Na absorption and K secretion

In low pH, aldosterone act on intercalated cell of collecting ducts to increase secretion of H+

insoluble in plasma, loosely bound to serum albumin and to transcortin

Pathology

Excess secretion leads to retention of Na, expansion of ECF vol, decreased K (Hypokalemia) and alkalosis

Deficiency leads to Na wasting, contracting of ECF vol, increase blood K+(hyperkalemia) and acidosis

aldosterone elevated and renin low -> primary pathology
aldosterone elevated and renin elevated -> secondary

Glucocorticoids

regulated by HPA axis, most common being cortisol which exibits circadian rhythem

Highest around time of awakening, lowest around midnight, and is related to sleep-wake patterns rather than dark-light.

Regulates cortisol secretion during times of stress

Physical

Hypoglycemia

Trauma

Heavy exercise

Dehydration

Psychological

Acute anxiety

Chronic anxiety

feedback loop

hypothalamus releases Corticotropin Releasing Hormone, which stimulates pituitary to secrete a large transcript called ProOpioMelanoCortin, which is cleaved to yield ACTH and endorphin (acts within CNS as an endogenous opoid)

ACTH (adrenocorticotrophin) stimulates cells of zona fasiculata to take up cholesterol and synthesize and release cortisol

As plasma cortisol rises, -ve feeddback to inhibit further secretion of ACTH and CRH

Breakdown of PROMC also produces melanin stimulating hormone (MSH), causing darkening of skin

ADH potentiates secretion of ACTH in presence of CRH

Not soluble in plasma, most bound to corticosteroid binding globulin, some to albumin with even lesser being free (only free available for binding to receptors)

Physiologic effects

Catabolic hormones, promte mobilization of fuel stores (protein in skeletal muscle, fatty acids and glycerol from adipose tissue)

Amino acids and glycerol converted by liver to glycogen, which is released into blood as glucose

Liver convert free fatty acids to ketones

combined effect of cortisol on three target organs is REINFORCEMENT

metabolic effects

Basal: increase gluconeogenesis in liver and lipolysis of fat

Excess (or pharmalogical doses) increase gluconeogenesis in liver, anti-inflammatory, immuno-suppressive, degradation of muscle, bone and skin, lipolysis of peripheral fat but deposition of visceral fat

  • inhibits GH, thyroid hormone, insulin and sex steroids on target tissues
  • Still used against asthma and rejection of transplants or inflammation

Mobilization of fuel stores, increased visceral fat and insulin resistnace

During stress, adrenal medulla also receive stimulation by sympathetic nervous system, releasing epinephrine

  • inhibits insulin secretion from pancreas and moblization of triglycerides (lipolysis) from fat, thus keeping blood glucose levels high

Net effect of cortisol and EPI increases blood glucose, wasting of bone and muscle, loss of peripheral fats and deposition of omentum fats (neuropeptide Y upregulated, promoting growth)

insufficient cortisol -> increased resistance to insulin and poor capacity to generate substrate for gluconeogenesis -> hypoglycemic

molecular mechanism of action

Diffuse across plasma membrane and bind to intracellular receptors (GR), which was maintain in an inactive state by a chaperone

  • glucocorticoid displace chaperone and steroid-GR complex moves to the nucleus

In nucleus, GR bind to glucocorticoid binding element (GRE) to control transcription, response time 60-90 mins

Cortisol similar in structure to mineralcorticoid, can bind to the receptor (MR)
under normal circumstances, specificity to mineralcorticoid is maintained through

carrier CBG has higher binding affinity for cortisol, lowering free cortisol in blood

Tissue sensitive to mineralcorticoids express enzyme 11,B-hydroxysteroid dehydrogenase type 2(11BHSD-2) which converts cortisol to cortisone (inactive) and cant bind to MR

  • type 2 found in peripheral tissues
  • type 1 coverts inactive cortisone to active cortisol in target tissues, leading to lipolysis

adrenal Pathophysiology

Addisons disease

entire adrenal gland destroyed or dysfunctional

Absence/lack of mineralcorticoid and blucocortic steroids

low serum Na and elevated serum K, low BP and increased skin pigmentation (no feedback from cortisol, excess ACTH)

unless mineralcorticoid is administered, K levels increase markedly with daily diet intake, could lead to cardiac arrest

Primary hyperaldosteronism (or Conn syndrome)

Excess aldosterone due to tumor in zona glomerulosa or bilateral hyperplasia of zona glomerulosa

decrease in K+ (hypokalemia), which can lead to arrhythmias and muscle weakness

Water retension an dhypertension

Renin should be decreased

Cushing's syndrome/disease

excess cortisol may be ACTH dependent (disease) or ACTH independent(syndrome, primary)

Mobilize glucose, hyperglycemia not correctde by insulin secretion (insulin resistant diabetes)

redistribution of fat from periphery to omentum fats

tanned in areas that receive no sunlight (due to excess ACTH)

thinning of skin as cortisol degrades the skin

Congenital bilateral adrenal hyperplasia

growth of cortex due to insufficiency of cortisol and consequent loss of -ve feedback on pituitary

DHEA does not feedback

congenital deficiencies occur in 17,21 or 11 hydroxylase

Catecholamines (medulla)

Epinephrine is primary catecholamine of adrenal, secreted by chromaffin cells, directly controlled by sympathetic nervous system

enzyme responsible for converting norepinephrine to epinephrine is induced by cortisol

norepinephrine is primary catecholamine of sympathetic nervous system

synthesis and secretion

begins with tyrosine, taken up by chromaffin cells in medulla and converted to NorEpi or Epi, which are then stored in granules

Secretion is stimulated by activation of sympathetic fibers of autonomic nervous system

Activated by stress, including exercise, hypoglycemia and trauma

adrenergic receptors and mechanism of action

bind to adrenergic receptors (a and B) on surface of target cells

Coupled to G proteins, which either stimulate or inhibit intracellular signalling pathways

involve changes in cAMP and free Ca

Physiological effects

Same effect on organs as direct stimulation by sympathetic nerves, although effect is more longer lasting

Can affect tissues and cells that are not innervated

effects

Increase HR and contraction of heart muscle

Vasoconstriction, increasing resistance and arterial blood pressure

Dilation of bronchioles to assist pulmonary ventilation

increased metabolic rate, oxygen consumption and heat production

Stimulation of liplysis in adipose cells and lactate from muscle to provide additional sources of energy in fight or flight response

Inhibit insulin release from pancrease to main elevated blood glucose

Epi is secreted with cortisol under stressful conditions, and acts on pancreatic islets to inhibit insulin secretion, removing opposing effects of insulin and increase secretion of glucagon

Net effect of Epi, cortisol and glucagon on blood glucose exceeds additive effect of ea hormone alone, and is called synergy